相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood-follow-up after CD19 recovery
Anne-Laure Sellier-Leclerc et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome
Aditi Sinha et al.
PEDIATRIC NEPHROLOGY (2012)
Disruption of PTPRO Causes Childhood-Onset Nephrotic Syndrome
Fatih Ozaltin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling Pathway
Tom Nijenhuis et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
A Review of the Mammalian Unfolded Protein Response
Anirikh Chakrabarti et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
Pietro Ravani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Clinical Utility of Genetic Testing in Children and Adults with Steroid-Resistant Nephrotic Syndrome
Sheila Santin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The story of Notch and chronic kidney disease
Shuchita Sharma et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Investigational Notch and Hedgehog inhibitors - therapies for cardiovascular disease
Eileen M. Redmond et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications
Maurizio Bruschi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Development of the Nephrotic Syndrome During Treatment of Crohn's Disease With Adalimumab
Alok Gupta et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis
Shreeram Akilesh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome
Tahar T. G. Gargah et al.
JOURNAL OF NEPHROLOGY (2011)
INF2 Is Another Piece of the Jigsaw Puzzle for FSGS
York Pei
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase
Satoshi Kinugasa et al.
KIDNEY INTERNATIONAL (2011)
Clinical trial of focal segmental glomerulosclerosis in children and young adults
Debbie S. Gipson et al.
KIDNEY INTERNATIONAL (2011)
mTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome
Noriko Ito et al.
LABORATORY INVESTIGATION (2011)
Comparison of Direct Action of Thiazolidinediones and Glucocorticoids on Renal Podocytes: Protection from Injury and Molecular Effects
Shipra Agrawal et al.
MOLECULAR PHARMACOLOGY (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
The podocyte as a direct target of immunosuppressive agents
Eva Schoenenberger et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Minimal change disease as a modifiable podocyte paracrine disorder
Changli Wei et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Genetics in Clinical Practice: Nephrotic and Proteinuric Syndromes
Hugh J. McCarthy et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Antioxidant status of children with idiopathic nephrotic syndrome
Om P. Mishra et al.
PEDIATRIC NEPHROLOGY (2011)
Neonatal nephrotic syndrome associated with placental transmission of proinflammatory cytokines
Farahnak Assadi
PEDIATRIC NEPHROLOGY (2011)
Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration
Shuichiro Fujinaga et al.
PEDIATRIC NEPHROLOGY (2011)
Rituximab for refractory cases of childhood nephrotic syndrome
Jameela A. Kari et al.
PEDIATRIC NEPHROLOGY (2011)
Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?
Sermin A. Saadeh et al.
PEDIATRIC NEPHROLOGY (2011)
Elevated serum interleukin-7 level in idiopathic steroid-sensitive nephrotic syndrome
Takahiro Kanai et al.
PEDIATRICS INTERNATIONAL (2011)
Rituximab for childhood refractory nephrotic syndrome
Kazumoto Iijima
PEDIATRICS INTERNATIONAL (2011)
Rituximab's New Therapeutic Target: The Podocyte Actin Cytoskeleton
Andrew C. Chan
SCIENCE TRANSLATIONAL MEDICINE (2011)
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
Alessia Fornoni et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Partial Remission of Resistant Nephrotic Syndrome After Oral Galactose Therapy
Matjaz Kopac et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Correlation between Oxidative Stress and Thyroid Function in Patients with Nephrotic Syndrome
Sangita U. Sawant et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2011)
Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury
Ruma Pengal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
Pantelis A. Sarafidis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Melanie S. Joy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report
Ashima Gulati et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Role of Rituximab Therapy in Glomerulonephritis
David Jayne
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Sydney C. W. Tang et al.
KIDNEY INTERNATIONAL (2010)
Glomerular diseases: genetic causes and future therapeutics
Chih-Kang Chiang et al.
NATURE REVIEWS NEPHROLOGY (2010)
Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection
Hua-Feng Liu et al.
NEPHROLOGY (2010)
Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome
Valderez Raposo de Mello et al.
PEDIATRIC NEPHROLOGY (2010)
Rituximab in refractory nephrotic syndrome
Agnieszka Prytula et al.
PEDIATRIC NEPHROLOGY (2010)
Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations
Genevieve Benoit et al.
PEDIATRIC NEPHROLOGY (2010)
Rituximab efficiency in children with steroid-dependent nephrotic syndrome
Anne-Laure Sellier-Leclerc et al.
PEDIATRIC NEPHROLOGY (2010)
Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies
Albert Bensman et al.
PEDIATRIC NEPHROLOGY (2010)
Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome
Mohan Shenoy et al.
PEDIATRIC NEPHROLOGY (2010)
Severe Ulcerative Colitis After Rituximab Therapy
Daniela S. Ardelean et al.
PEDIATRICS (2010)
Notch Activation Differentially Regulates Renal Progenitors Proliferation and Differentiation Toward the Podocyte Lineage in Glomerular Disorders
Laura Lasagni et al.
STEM CELLS (2010)
TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology
Stuart E. Dryer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
Swati Choudhry et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription
Johannes Schloendorff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
PKC-alpha Modulates TGF-beta Signaling and Impairs Podocyte Survival
Irini Tossidou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2009)
PKC inhibitors: potential in T cell-dependent immune diseases
Gottfried Baier et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Protein kinase C intervention-the state of play
Jon Roffey et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Hae-Young Yong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology
Eduardo Machuca et al.
HUMAN MOLECULAR GENETICS (2009)
Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome
Noritomo Kurosu et al.
INTERNAL MEDICINE (2009)
Rapid and complete resolution of ascites and hydrothorax due to nephrotic syndrome caused by renal amyloidosis in a patient with juvenile chronic arthritis treated with adalimumab
Beata Nowak et al.
JOINT BONE SPINE (2009)
The oxido-redox potential of albumin Methodological approach and relevance to human diseases
Giovanni Candiano et al.
JOURNAL OF PROTEOMICS (2009)
Patients with ACTN4 Mutations Demonstrate Distinctive Features of Glomerular Injury
Joel M. Henderson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Loss of Podocyte aPKCλ/ι Causes Polarity Defects and Nephrotic Syndrome
Tobias B. Huber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Up regulation of the GRP-78 and GADD-153 and down regulation of Bcl-2 proteins in primary glomerular diseases: a possible involvement of the ER stress pathway in glomerulonephritis
Suchita Markan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta
Toru Kawai et al.
LABORATORY INVESTIGATION (2009)
FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy
Eric De Smet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Peroxisome Proliferator-Activated Receptor Gamma Agonists in Kidney Disease - Future Promise, Present Fears
Zhiguo Mao et al.
NEPHRON CLINICAL PRACTICE (2009)
The Pathogenic Role of Notch Activation in Podocytes
Thiruvur Niranjan et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2009)
Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab
Ajay P. Sharma et al.
PEDIATRIC NEPHROLOGY (2009)
Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2009)
p38MAPK: stress responses from molecular mechanisms to therapeutics
Lydia R. Coulthard et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Co-regulation of Gremlin and Notch signalling in diabetic nephropathy
David W. Walsh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Therapeutical relevance of MAP-kinase inhibitors in renal diseases:: Current knowledge and future clinical perspectives
M. Teresa Grande et al.
CURRENT MEDICINAL CHEMISTRY (2008)
The role of tacrolimus in renal transplantation
Lyndsey J. Bowman et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Specificity of signaling from MAPKs to MAPKAPKs:: Kinases' Tango Nuevo
Matthias Gaestel
FRONTIERS IN BIOSCIENCE (2008)
Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab
Megha Suri et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Ectopic notch activation in developing podocytes causes glomerulosclerosis
Aoife M. Waters et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Notch signaling: A common pathway of injury in podocytopathies?
Laura Barisoni
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Rituximab treatment of idiopathic membranous nephropathy
F. C. Fervenza et al.
KIDNEY INTERNATIONAL (2008)
The Notch pathway in podocytes plays a role in the development of glomerular disease
Thiruvur Niranjan et al.
NATURE MEDICINE (2008)
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
Christian Faul et al.
NATURE MEDICINE (2008)
Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study
Lakshmanan Senthil Nayagam et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Podocyte injury induced by albumin overload in vivo and in vitro: Involvement of TGF-beta and p38 MAPK
Shigetaka Yoshida et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2008)
Do glutathione-S-transferase polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephrotic syndrome?
Sheetal V. Sharda et al.
PEDIATRIC NEPHROLOGY (2008)
Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome - a randomized controlled multicentre trial by the Arbeitsgemeinschaft fur Padiatrische Nephrologie
Christian Plank et al.
PEDIATRIC NEPHROLOGY (2008)
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases
Vincent Guigonis et al.
PEDIATRIC NEPHROLOGY (2008)
Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria
Marcelo F. O. Souto et al.
PEDIATRIC RESEARCH (2008)
Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity
Virginia J. Savin et al.
TRANSLATIONAL RESEARCH (2008)
Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis:: role of p38MAPKα
K. Polzer et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children
Sanjeev Gulati et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Rituximab for refractory focal segmental glomerulosclerosis
Makiko Nakayama et al.
PEDIATRIC NEPHROLOGY (2008)
Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces
Masanori Kitamura
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated
Jochen H. H. Ehrich et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
Dae Ryong Cha et al.
DIABETES (2007)
Molecular insights into segmentation along the proximal-distal axis of the nephron
Raphael Kopan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Rituximab in patients with the steroid-resistant nephrotic syndrome
Arvind Bagga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?
Graham C. Smith
PEDIATRIC NEPHROLOGY (2007)
A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: Recovery of renal function after five months on dialysis
Lily Oliveira et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2007)
PPAR-γ agonist protects podocytes from injury
T. Kanjanabuch et al.
KIDNEY INTERNATIONAL (2007)
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
Kin-Wai Lai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1β or IL-6
Abdulmunem Sheryanna et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron
Hui-Teng Cheng et al.
DEVELOPMENT (2007)
Nephrotic syndrome in the first year of life: Two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)
Bernward G. Hinkes et al.
PEDIATRICS (2007)
Protein kinases as small molecule inhibitor targets in inflammation
M. Gaestel et al.
CURRENT MEDICINAL CHEMISTRY (2007)
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
Liliane Michalik et al.
PHARMACOLOGICAL REVIEWS (2006)
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
Bernward Hinkes et al.
NATURE GENETICS (2006)
Downloadable computer models for maintenance but not acute renal replacement therapy
M. R. Marshall et al.
KIDNEY INTERNATIONAL (2006)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders
K. Hasselbacher et al.
KIDNEY INTERNATIONAL (2006)
Rituximab for idiopathic membranous nephropathy: Who can benefit?
Piero Ruggenenti et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis
C. D. Garcia et al.
TRANSPLANTATION PROCEEDINGS (2006)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis
H-C Yang et al.
KIDNEY INTERNATIONAL (2006)
Differential risk of remission and ESRD in childhood FSGS
DS Gipson et al.
PEDIATRIC NEPHROLOGY (2006)
Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein
P Duann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus
Rajendra Bhimma et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization
RF Ransom et al.
KIDNEY INTERNATIONAL (2005)
Oxidative stress in children with kidney disease
EL Pavlova et al.
PEDIATRIC NEPHROLOGY (2005)
The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney
HT Cheng et al.
KIDNEY INTERNATIONAL (2005)
Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome
M Koshikawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome
A Ece et al.
PEDIATRIC NEPHROLOGY (2005)
The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and-P1
U Vester et al.
PEDIATRIC NEPHROLOGY (2005)
Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome
H Tanaka et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Oxidative stress in a rat model of nephrosis can be quantified by electron spin resonance
H Nakakura et al.
PEDIATRIC NEPHROLOGY (2004)
Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome
K Loeffler et al.
PEDIATRIC NEPHROLOGY (2004)
p38 mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: Correlation with renal injury
C Stambe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome
JG van den Berg et al.
CLINICAL SCIENCE (2004)
Diminished loss of Proteoglycans and lack of albuminuria in protein kinase C-α-deficient diabetic mice
J Menné et al.
DIABETES (2004)
Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants
MJ Chun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Defective trafficking of nephrin missense mutants rescued by a chemical chaperone
XL Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside
V Vega-Warner et al.
KIDNEY INTERNATIONAL (2004)
Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome
K Mori et al.
PEDIATRIC NEPHROLOGY (2004)
Early use of plasmapheresis for recurrent post-transplant FSGS
M Pradhan et al.
PEDIATRIC NEPHROLOGY (2003)
Implications of serum TNF-β and IL-13 in the treatment response of childhood nephrotic syndrome
YL Tain et al.
CYTOKINE (2003)
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis
C Stambe et al.
KIDNEY INTERNATIONAL (2003)
Oxidative stress in pediatric nephrotic syndrome
R Kamireddy et al.
CLINICA CHIMICA ACTA (2002)
Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells
AV Cybulsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats
CD Agardh et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2002)
Cardiovascular disease in pediatric chronic dialysis patients
BM Chavers et al.
KIDNEY INTERNATIONAL (2002)
Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome
K Iijima et al.
KIDNEY INTERNATIONAL (2002)
Extracorporeal plasma treatment in primary and recurrent focal segmental glomerular sclerosis: A review
T Bosch et al.
THERAPEUTIC APHERESIS (2001)
Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats
LJ Ma et al.
KIDNEY INTERNATIONAL (2001)
A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children
K Latta et al.
PEDIATRIC NEPHROLOGY (2001)
分享论文
